iTeos Therapeutics与GSK价值20亿美元的TIGIT合作未达预期后将关闭公司iTeos Therapeutics to Shut Down After $2 Billion TIGIT Collaboration with GSK Falls Short

动脉网
29 May

by Mark Chiang马克·蒋Share To分享到iTeos Therapeutics has announced plans to cease operations following the failure of its TIGIT asset, which was developed in partnership with GSK. The company intends to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10